Palvella Therapeutics Q2 EPS $(1.52) Misses $(1.14) Estimate
Palvella Therapeutics (NASDAQ:PVLA) reported quarterly losses of $(1.52) per share which missed the analyst consensus estimate of $(1.14) by 33.33 percent. This is a 76.74 percent decrease over losses of $(0.86) per
Palvella lost more money per share than experts thought it would, and its losses got much bigger compared to last year. When a company's losses grow faster than people expected, it's a sign to watch whether the company can turn things around soon.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.